CIK: 0001882053 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $304,969 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MDT | MEDTRONIC PLC | 428,789 | $40,838 | 13.4% | $87.09 | +4.8% | SHS | G5960L103 |
| MIRM | MIRUM PHARMACEUTICALS INC | 535,732 | $39,275 | 12.9% | $30.59 | +107.8% | COM | 604749101 |
| IONS | IONIS PHARMACEUTICALS INC | 417,833 | $27,335 | 9.0% | $48.82 | 0.0% | COM | 462222100 |
| CI | THE CIGNA GROUP | 82,972 | $23,917 | 7.8% | $293.97 | -0.3% | COM | 125523100 |
| BBIO | BRIDGEBIO PHARMA INC | 460,282 | $23,907 | 7.8% | $48.77 | 0.0% | COM | 10806X102 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 166,414 | $23,361 | 7.7% | $114.68 | +18.2% | COM | 64125C109 |
| RAPT | RAPT THERAPEUTICS INC | 782,461 | $20,180 | 6.6% | $13.09 | 0.0% | COM NEW | 75382E208 |
| UNH | UNITEDHEALTH GROUP INC | 58,112 | $20,066 | 6.6% | $374.94 | -20.3% | COM | 91324P102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 328,546 | $17,794 | 5.8% | $65.02 | -12.0% | COM | 09061G101 |
| ICLR | ICON PLC | 95,832 | $16,771 | 5.5% | $141.84 | +18.0% | SHS | G4705A100 |
| COGT | COGENT BIOSCIENCES INC | 945,042 | $13,571 | 4.4% | $11.85 | 0.0% | COM | 19240Q201 |
| KOD | KODIAK SCIENCES INC | 715,877 | $11,719 | 3.8% | $8.62 | 0.0% | COM | 50015M109 |
| LIVN | LIVANOVA PLC | 167,932 | $8,796 | 2.9% | $50.34 | 0.0% | SHS | G5509L101 |
| QURE | UNIQURE NV | 147,317 | $8,599 | 2.8% | $18.16 | 0.0% | SHS | N90064101 |
| CLPT | CLEARPOINT NEURO INC | 283,912 | $6,186 | 2.0% | $11.78 | 0.0% | COM | 18507C103 |
| ABEO | ABEONA THERAPEUTICS INC | 502,854 | $2,655 | 0.9% | $5.69 | +11.4% | COM NEW | 00289Y206 |